Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Dr. Crawford on the Drawbacks of PSA Screening

April 8th 2011

Dr. Crawford Discusses the Benefits of PCA3 Testing

April 8th 2011

Bicalutamide Therapy Plus Radiation Improves PFS

April 8th 2011

Bicalutamide during and after radiation therapy reduced the risk of progression and the risk of metastatic disease in men with a rising prostate-specific antigen

Dr. Sandler on the Importance of Radiation Therapy

April 7th 2011

Dr. Crawford on Moving Prostate Cancer Field Forward

April 7th 2011

Dr. Gomella Discusses Interdisiplinary Treatment

April 6th 2011

Prostate Cancer Advances From the Past 10 Years

April 6th 2011

Recent Developments in Prostate Cancer

April 5th 2011

Hormonal and Radiation Therapy in Prostate Cancer

April 5th 2011

TAK-700 in Localized Prostate Cancer Clinical Trials

April 4th 2011

Dr. Howard Sandler from Cedars-Sinai Medical Center discusses the TAK-700 in Localized Prostate Cancer Clinical Trials

Provenge Gains Approval From Medicare Panel

March 31st 2011

The federal agency that determines Medicare reimbursements this week proposed to fully cover the cost of Provenge

Dr. Gomella on Jefferson's Multidisciplinary Cancer Center

March 31st 2011

Dr. Dreicer on the Need to Diagnose and Treat Efficiently

March 31st 2011

Dr. Sandler on Clinical Trials for Liase Inhibitors

March 31st 2011

Dr. Dreicer on Newer Prostate Therapy Survival Benefits

March 30th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, Discusses How New Treatments Have Improved Survival

Dr. Gomella on Current Prostate Screening Procedures

March 30th 2011

In an interview at the 2011 IPCC Meeting in New York, Leonard G. Gomella, MD, from Jefferson Kimmel Cancer Center, discusses prostate cancer screening procedures.

Dr. Dreicer on Prostate Cancer Combination Therapy

March 29th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, discusses the various treatments that prostate cancer patients may receive in combination.

Dr. Sandler on Candidates for Liase Inhibitor Clinical Trials

March 29th 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, discusses candidates for liase inhibitor clinical trials.

Traditional LHRH Agonists Versus Newer Drugs

March 29th 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, compares the efficacy of the mechanism of action for traditional LHRH agonists to newer androgen deprivation therapies

Dr. Petrylak Explains Prostate Cancer Clinical Trial Difficulties

March 28th 2011

Daniel P. Petrylak, MD, from Columbia University Medical Center Explains the Difficulties Facing During Prostate Cancer Clinical Trials